The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?

References

• Uttley L, Carroll C, Wong R, et al. Creutzfeldt-Jakob disease (CJD) is a fatal disease presenting with rapidly progressive dementia, and most patients die within a year of clinical onset. Lancet Infect Dis. 2020;20:e2–e10. doi: 10.1016/S1473-3099(19)30615-2
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363–13383. doi: 10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216(4542):136–144. doi: 10.1126/science.6801762
   PubMed Web of Science ®Google Scholar
• Hermann P, Appleby B, Brandel J-P, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20:235–246. doi: 10.1016/S1474-4422(20)30477-4
   PubMed Web of Science ®Google Scholar
• 30th Annual Report 2021. Creutzfeldt-Jakob disease surveillance in the UK. Edinburgh: National CJD Research and Surveillance Unit, 1998. [cited 2023 Aug 5]; Available from: https://www.cjd.ed.ac.uk/sites/default/files/report30.pdf
   Google Scholar
• Puoti G, Bizzi A, Forloni G, et al. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012;11(7):618–628. doi: 10.1016/S1474-4422(12)70063-7
   PubMed Web of Science ®Google Scholar
• Geschwind MD. Prion diseases. Continuum (Minneap Minn). 2015;21(6):1612–1638. doi: 10.1212/CON.0000000000000251
   PubMedGoogle Scholar
• Zerr I, Parchi P. Sporadic Creutzfeldt-Jakob disease. Handb Clin Neurol. 2018;153:155–174.
   PubMedGoogle Scholar
• Krasnianski A, Kaune J, Jung K, et al. First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol. 2014;261(9):1811–1817. doi: 10.1007/s00415-014-7410-z
   PubMed Web of Science ®Google Scholar
• Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996;39:767–778. doi: 10.1002/ana.410390613
   PubMed Web of Science ®Google Scholar
• Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46(2):224–233. doi: 10.1002/1531-8249(199908)46:2<224:AID-ANA12>3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• Kovács GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118(2):166–174. doi: 10.1007/s00439-005-0020-1
   PubMed Web of Science ®Google Scholar
• Mead S, Lloyd S, Collinge J. Genetic factors in mammalian prion diseases. Ann Rev Genet. 2019;53(1):117–147. doi: 10.1146/annurev-genet-120213-092352
   PubMedGoogle Scholar
• Zerr I, Schmitz M, Genetic Prion Disease. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2003 Mar 27. [cited 2023 Aug 5]; 1993–2023 Available from: https://www.ncbi.nlm.nih.gov/books/NBK1229/
   Google Scholar
• Goldman JS, Vallabh SM. Genetic counseling for prion disease: updates and best practices. Genet Med. 2022;24(10):1993–2003. doi: 10.1016/j.gim.2022.06.003
   PubMed Web of Science ®Google Scholar
• Medori R, Tritschler HJ. Prion protein gene analysis in three kindreds with fatal familial insomnia (FFI): codon 178 mutation and codon 129 polymorphism. Am J Hum Genet. 1993;53:822–827.
   PubMed Web of Science ®Google Scholar
• Parchi P, Petersen RB, Chen SG, et al. Molecular pathology of fatal familial insomnia. Brain Pathol. 1998;8:539–548. doi: 10.1111/j.1750-3639.1998.tb00176.x
   PubMed Web of Science ®Google Scholar
• Doh-Ura K, Tateishi J, Sasaki H, et al. Pro—-leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun. 1989;163:974–979. doi: 10.1016/0006-291X(89)92317-6
   PubMed Web of Science ®Google Scholar
• Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66(1):255–265. doi: 10.1093/bmb/66.1.255
   PubMedGoogle Scholar
• Koutsoumanis K, Allende A, Alvarez-Ordoňez A, et al. Update on chronic wasting disease (CWD) III. EFSA J. 2019;17(11):e05863. doi: 10.2903/j.efsa.2019.5863
   PubMed Web of Science ®Google Scholar
• Rivera NA, Brandt AL, Novakofski JE, et al. Chronic wasting disease in cervids: prevalence, impact and management strategies. Vet Med. 2019;10:123–139. doi: 10.2147/VMRR.S197404
   Google Scholar
• Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and characterization. Br Med Bull. 2003;66:213–239. doi: 10.1093/bmb/66.1.213
   PubMed Web of Science ®Google Scholar
• Watson N, Brandel JP, Green A, et al. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Rev Neurol. 2021;17:362–379. doi: 10.1038/s41582-021-00488-7
   PubMed Web of Science ®Google Scholar
• Zeidler M, Gibbs CJ. WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease. Francois Meslin, Geneva: World Health Organization; 1998. [cited 2023 Aug 4]; Available from: https://apps.who.int/iris/bitstream/handle/10665/66394/WHO_EMC_ZDI_98.11.pdf?sequence=1&isAllowed=y
   Google Scholar
• Diagnostic criteria. 1.SPORADIC CJD (from 2017). Edinburgh: The National CJD Research & Surveillance Unit (NCJDRSU); 2017. [cited 2023 Aug 5]; Available from: http://www.cjd.ed.ac.uk/sites/default/files/criteria.pdf
   Google Scholar
• CDC’s Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD). 2018. Atlanta: centers for disease Control and Prevention (CDC), 2018. [cited 2023 Aug 5]; Available from: https://www.cdc.gov/prions/cjd/diagnostic-criteria.html
   Google Scholar
• Hermann P, Zerr I. Rapidly progressive dementias - aetiologies, diagnosis and management. Nat Rev Neurol. 2022;18:363–376.
   PubMed Web of Science ®Google Scholar
• Mead S, Rudge P. CJD mimics and chameleons. Pract Neurol. 2017 Apr;17(2):113–121. doi: 10.1136/practneurol-2016-001571
   PubMedGoogle Scholar
• Mbizvo GK, Ziso B, Larner AJ. Epilepsy and prion diseases: a narrative review. Epilepsy Behav. 2021;115:107630. doi: 10.1016/j.yebeh.2020.107630
   PubMed Web of Science ®Google Scholar
• Baiardi S, Capellari S, Bartoletti Stella A, et al. Unusual clinical presentations challenging the early clinical diagnosis of Creutzfeldt-Jakob disease. J Alzheimers Dis. 2018;64(4):1051–1065. doi: 10.3233/JAD-180123
   PubMed Web of Science ®Google Scholar
• Mead S, Reilly MM. A new prion disease: relationship with central and peripheral amyloidosis. Nat Rev Neurol. 2015;11:90–97. doi: 10.1038/nrneurol.2014.263
   PubMed Web of Science ®Google Scholar
• Hsiao K, Meiner Z, Kahana E, et al. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med. 1991;324:1091–1097. doi: 10.1056/NEJM199104183241604
   PubMed Web of Science ®Google Scholar
• Breithaupt M, Romero C, Kallenberg K, et al. Magnetic resonance imaging in E200K and V210I mutations of the prion protein gene. Alzheimer Dis Assoc Disord. 2013;27(1):87–90. doi: 10.1097/WAD.0b013e31824d578a
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Teil C, Lenne M, et al. Mutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease. J Neurol Sci. 1999;168(2):141–144. doi: 10.1016/S0022-510X(99)00179-3
   PubMed Web of Science ®Google Scholar
• Qina T, Sanjo N, Hizume M, et al. Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open. 2014;4(5):e004968. doi: 10.1136/bmjopen-2014-004968
   PubMed Web of Science ®Google Scholar
• Webb TE, Poulter M, Beck J, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain. 2008;131(10):2632–2646. doi: 10.1093/brain/awn202
   PubMedGoogle Scholar
• Tesar A, Matej R, Kukal J, et al. Clinical Variability in P102L Gerstmann-Sträussler-Scheinker Syndrome. Ann Neurol. 2019;86:643–652. doi: 10.1002/ana.25579
   PubMed Web of Science ®Google Scholar
• Zhang J, Chu M, Tian Z, et al. Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions. J Neurol Neurosurg Psychiatry. 2022;93(3):291–297. doi: 10.1136/jnnp-2021-327247
   PubMed Web of Science ®Google Scholar
• Moore RC, Xiang F, Monaghan J, et al. Huntington disease phenocopy is a familial prion disease. Am J Hum Genet. 2001;69(6):1385–1388. doi: 10.1086/324414
   PubMed Web of Science ®Google Scholar
• Oldoni E, Fumagalli GG, Serpente M, et al. PRNP P39L variant is a rare cause of frontotemporal dementia in Italian population. J Alzheimers Dis. 2016;50(2):353–357. doi: 10.3233/JAD-150863
   PubMed Web of Science ®Google Scholar
• Gambetti P, Parchi P, Petersen RB, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol. 1995;5(1):43–51. doi: 10.1111/j.1750-3639.1995.tb00576.x
   PubMed Web of Science ®Google Scholar
• Young K, Clark HB, Piccardo P, et al. Gerstmann-Sträussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Brain Res Mol Brain Res. 1997;44:147–150. doi: 10.1016/S0169-328X(96)00251-3
   PubMedGoogle Scholar
• Ghetti B, Piccardo P, Spillantini MG, et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A. 1996;93(2):744–748. doi: 10.1073/pnas.93.2.744
   PubMed Web of Science ®Google Scholar
• Mead S, Gandhi S, Beck J, et al. A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med. 2013;369(20):1904–1914. doi: 10.1056/NEJMoa1214747
   PubMed Web of Science ®Google Scholar
• Hamada S, Takahashi-Iwata I, Satoh K, et al. Genetic Creutzfeldt‒Jakob disease with 5-octapeptide repeats presented as frontotemporal dementia. Hum Genome Var. 2023;10(1):10. doi: 10.1038/s41439-023-00237-w
   PubMed Web of Science ®Google Scholar
• Nan H, Liu L, Chen Z, et al. Octapeptide repeat alteration mutations of the prion protein gene in clinically diagnosed Alzheimer’s disease and frontotemporal dementia. Clinical Genetics. 2023;104(3):350–355. Online ahead of print. doi: 10.1111/cge.14354
   PubMed Web of Science ®Google Scholar
• Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132:2659–2568.
   PubMed Web of Science ®Google Scholar
• Rudge P, Hyare H, Green A, et al. Imaging and CSF analyses effectively distinguish CJD from its mimics. J Neurol Neurosurg Psychiatry. 2018;89(5):461–466. doi: 10.1136/jnnp-2017-316853
   PubMed Web of Science ®Google Scholar
• Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;91(4):e331–e338. doi: 10.1212/WNL.0000000000005860
   PubMed Web of Science ®Google Scholar
• Bizzi A, Pascuzzo R, Blevins J, et al. Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging. JAMA Neurol. 2020;77(9):1141–1149. doi: 10.1001/jamaneurol.2020.1319
   PubMed Web of Science ®Google Scholar
• Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76(20):1711–1719. doi: 10.1212/WNL.0b013e31821a4439
   PubMed Web of Science ®Google Scholar
• Staffaroni AM, Elahi FM, McDermott D, et al. Neuroimaging in dementia. Semin Neurol. 2017;37(5):510–537. doi: 10.1055/s-0037-1608808
   PubMed Web of Science ®Google Scholar
• Carswell C, Thompson A, Lukic A, et al. MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC neurol. 2012;12(1):153. doi: 10.1186/1471-2377-12-153
   PubMedGoogle Scholar
• Yasuda M, Sugiyama A, Hokkoku H, et al. Propagation of diffusion-weighted MRI abnormalities in the preclinical stage of sporadic Creutzfeldt-Jakob disease. Neurology. 2022;99(16):699–702. doi: 10.1212/WNL.0000000000201221
   PubMed Web of Science ®Google Scholar
• Koizumi R, Ueda N, Mugita A, et al. Case report: extremely early detection of preclinical magnetic resonance imaging abnormality in Creutzfeldt-Jakob disease with the V180I mutation. Front Neurol. 2021;12:751750. doi: 10.3389/fneur.2021.751750
   PubMed Web of Science ®Google Scholar
• Jesuthasan A, Sequeira D, Hyare H, et al. Assessing initial MRI reports for suspected CJD patients. J Neurol. 2022;269(8):4452–4458. doi: 10.1007/s00415-022-11087-x
   PubMed Web of Science ®Google Scholar
• Gaudino S, Gangemi E, Colantonio R, et al. Neuroradiology of human prion diseases, diagnosis and differential diagnosis. Radiol Med. 2017;122(5):369–385. doi: 10.1007/s11547-017-0725-y
   PubMed Web of Science ®Google Scholar
• Meissner B, Kallenberg K, Sanchez-Juan P, et al. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology. 2009;72(23):1994–2001. doi: 10.1212/WNL.0b013e3181a96e5d
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Kitamoto T, Sato T, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology. 2005;64(4):643–648. doi: 10.1212/01.WNL.0000151847.57956.FA
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Sanjo N, Ae R, et al. MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type. J Neurol Neurosurg Psychiatry. 2020;91(11):1158–1165. doi: 10.1136/jnnp-2020-323231
   PubMed Web of Science ®Google Scholar
• Meissner B, Körtner K, Bartl M, et al. Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology. 2004;63:450–456. doi: 10.1212/01.WNL.0000136225.80445.C9
   PubMed Web of Science ®Google Scholar
• Pascuzzo R, Oxtoby NP, Young AL, et al. Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 2020;140:169–181. doi: 10.1007/s00401-020-02168-0
   PubMed Web of Science ®Google Scholar
• Appleby BS, Shetty S, Elkasaby M, et al. Genetic aspects of human prion diseases. Front Neurol. 2022;13:1003056. doi: 10.3389/fneur.2022.1003056
   PubMed Web of Science ®Google Scholar
• Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43(1):32–40. doi: 10.1002/ana.410430109
   PubMed Web of Science ®Google Scholar
• Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012;79(14):1499–1506. doi: 10.1212/WNL.0b013e31826d5fc3
   PubMed Web of Science ®Google Scholar
• Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006;67(4):637–643. doi: 10.1212/01.wnl.0000230159.67128.00
   PubMed Web of Science ®Google Scholar
• Altuna M, Ruiz I, Zelaya MV, et al. Role of biomarkers for the diagnosis of prion diseases: a narrative review. Med (Kaunas). 2022;58(4):473. doi: 10.3390/medicina58040473
   PubMed Web of Science ®Google Scholar
• Lattanzio F, Abu-Rumeileh S, Franceschini A, et al. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. Acta Neuropathol. 2017;133(4):559–578. doi: 10.1007/s00401-017-1683-0
   PubMed Web of Science ®Google Scholar
• Stoeck K, Sanchez-Juan P, Gawinecka J, et al. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain. 2012;135:3051–3061. doi: 10.1093/brain/aws238
   PubMed Web of Science ®Google Scholar
• Dorey A, Tholance Y, Vighetto A, et al. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. JAMA Neurol. 2015;72(3):267–275. doi: 10.1001/jamaneurol.2014.4068
   PubMed Web of Science ®Google Scholar
• Abu Rumeileh S, Lattanzio F, Stanzani M, et al. Diagnostic accuracy of a combined analysis of cerebrospinal fluid t-PrP, t-tau, p-tau, and Aβ42 in the differential diagnosis of Creutzfeldt-Jakob disease from Alzheimer’s disease with Emphasis on atypical disease variants. J Alzheimers Dis. 2017;55:1471–1480. doi: 10.3233/JAD-160740
   PubMed Web of Science ®Google Scholar
• Otto M, Wiltfang J, Cepek L, et al. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2002;58:192–197. doi: 10.1212/WNL.58.2.192
   PubMed Web of Science ®Google Scholar
• Franceschini A, Baiardi S, Hughson AG, et al. High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci Rep. 2017;7(1):10655. doi: 10.1038/s41598-017-10922-w
   PubMedGoogle Scholar
• Li QX, Varghese S, Sarros S, et al. CSF tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnostics. J Clin Neurosci. 2018;50:292–293. doi: 10.1016/j.jocn.2018.01.064
   PubMed Web of Science ®Google Scholar
• Skillbäck T, Rosén C, Asztely F, et al. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish mortality registry. JAMA Neurol. 2014;71(4):476–483. doi: 10.1001/jamaneurol.2013.6455
   PubMed Web of Science ®Google Scholar
• Riemenschneider M, Wagenpfeil S, Vanderstichele H, et al. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry. 2003;8:343–347. doi: 10.1038/sj.mp.4001220
   PubMed Web of Science ®Google Scholar
• Khalil M, Teunissen CE, Otto M, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577–589. doi: 10.1038/s41582-018-0058-z
   PubMed Web of Science ®Google Scholar
• Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res Ther. 2018;10(1):3. doi: 10.1186/s13195-017-0331-1
   PubMedGoogle Scholar
• Zerr I, Schmitz M, Karch A, et al. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases. Alzheimers Dement. 2018;14(6):751–763. doi: 10.1016/j.jalz.2017.12.008
   PubMed Web of Science ®Google Scholar
• Thompson AGB, Anastasiadis P, Druyeh R, et al. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Mol Psychiatry. 2021;26(10):5955–5966. doi: 10.1038/s41380-021-01045-w
   PubMed Web of Science ®Google Scholar
• Kanata E, Golanska E, Villar-Piqué A, et al. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease. J Clin Neurosci. 2019;60:124–127. doi: 10.1016/j.jocn.2018.09.031
   PubMed Web of Science ®Google Scholar
• Abu-Rumeileh S, Baiardi S, Polischi B, et al. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC. J Neurol. 2019;266:3136–3143. doi: 10.1007/s00415-019-09537-0
   PubMed Web of Science ®Google Scholar
• Llorens F, Kruse N, Schmitz M, et al. Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimer’s Dement. 2017;13(6):710–719. doi: 10.1016/j.jalz.2016.09.013
   PubMed Web of Science ®Google Scholar
• Mastrangelo A, Baiardi S, Zenesini C, et al. Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementia. Alzheimer’s Dement. 2021;13(1):e12214. doi: 10.1002/dad2.12214
   Web of Science ®Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411(6839):810–813. doi: 10.1038/35081095.
   PubMed Web of Science ®Google Scholar
• Bélondrade M, Nicot S, Mayran C, et al. Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent. Sci Rep. 2021;11:4058. doi: 10.1038/s41598-021-83630-1
   PubMed Web of Science ®Google Scholar
• Barria MA, Lee A, Green AJ, et al. Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid. J Pathol Clin Res. 2018;4:86–92. doi: 10.1002/cjp2.90
   PubMedGoogle Scholar
• Bougard D, Brandel JP, Bélondrade M, et al. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Sci Transl Med. 2016;8:370ra182. doi: 10.1126/scitranslmed.aag1257
   PubMed Web of Science ®Google Scholar
• Concha-Marambio L, Pritzkow S, Moda F, et al. Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci Transl Med. 2016;8(370):370ra183. doi: 10.1126/scitranslmed.aaf6188
   PubMed Web of Science ®Google Scholar
• Moda F, Gambetti P, Notari S, et al. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med. 2014;371:530–539. doi: 10.1056/NEJMoa1404401
   PubMed Web of Science ®Google Scholar
• Cazzaniga FA, Bistaffa E, De Luca CMG, et al. PMCA-Based detection of prions in the olfactory mucosa of patients with sporadic Creutzfeldt-Jakob disease. Front Aging Neurosci. 2022;14:848991. doi: 10.3389/fnagi.2022.848991
   PubMed Web of Science ®Google Scholar
• Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17(2):175–178. doi: 10.1038/nm.2294
   PubMed Web of Science ®Google Scholar
• Orrú CD, Groveman BR, Hughson AG, et al. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio. 2015;6(1):e02451–14. doi: 10.1128/mBio.02451-14
   PubMed Web of Science ®Google Scholar
• Bongianni M, Orrù C, Groveman BR, et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol. 2017;74(2):155–162. doi: 10.1001/jamaneurol.2016.4614
   PubMed Web of Science ®Google Scholar
• Foutz A, Appleby BS, Hamlin C, et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann Neurol. 2017;81(1):79–92. doi: 10.1002/ana.24833
   PubMed Web of Science ®Google Scholar
• Rhoads DD, Wrona A, Foutz A, et al. Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology. 2020;95:e1017–e1026. doi: 10.1212/WNL.0000000000010086
   PubMed Web of Science ®Google Scholar
• Cramm M, Schmitz M, Karch A, et al. Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol. 2016;53(3):1896–1904. doi: 10.1007/s12035-015-9133-2
   PubMed Web of Science ®Google Scholar
• Orrú CD, Bongianni M, Tonoli G, et al. A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med. 2014 7;371:519–529. doi: 10.1056/NEJMoa1315200.
   PubMed Web of Science ®Google Scholar
• Groveman BR, Orrú CD, Hughson AG, et al. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann Clin Transl Neurol. 2016;4:139–144. doi: 10.1002/acn3.378
   PubMed Web of Science ®Google Scholar
• Fiorini M, Iselle G, Perra D, et al. High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD. Int J Mol Sci. 2020;21(3):880. doi: 10.3390/ijms21030880
   PubMed Web of Science ®Google Scholar
• Orrú CD, Yuan J, Appleby BS, et al. Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease. Sci Transl Med. 2017;9(417):eaam7785. doi: 10.1126/scitranslmed.aam7785
   PubMed Web of Science ®Google Scholar
• Mammana A, Baiardi S, Rossi M, et al. Detection of prions in skin punch biopsies of Creutzfeldt-Jakob disease patients. Ann Clin Transl Neurol. 2020;7:559–564. doi: 10.1002/acn3.51000
   PubMed Web of Science ®Google Scholar
• Schmitz M, Silva Correia S, Hermann P, et al. Detection of prion protein seeding activity in tear fluids. N Engl J Med. 2023;388(19):1816–1817. doi: 10.1056/NEJMc2214647
   PubMed Web of Science ®Google Scholar
• Baiardi S, Redaelli V, Ripellino P, et al. Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2019;90(4):424–427. doi: 10.1136/jnnp-2018-319221
   PubMed Web of Science ®Google Scholar
• Shi S, Mitteregger-Kretzschmar G, Giese A, et al. Establishing quantitative real-time quaking-induced conversion (qRT-QuIC) for highly sensitive detection and quantification of PrPSc in prion-infected tissues. Acta Neuropathol Commun. 2013;1(1):44. doi: 10.1186/2051-5960-1-44
   PubMedGoogle Scholar
• Honda H, Mori S, Watanabe A, et al. Abnormal prion protein deposits with high seeding activities in the skeletal muscle, femoral nerve, and scalp of an autopsied case of sporadic Creutzfeldt-Jakob disease. Neuropathology. 2021;41:152–158. doi: 10.1111/neup.12717
   PubMed Web of Science ®Google Scholar
• Henderson DM, Denkers ND, Hoover CE, et al. Progression of chronic wasting disease in white-tailed deer analyzed by serial biopsy RT-QuIC and immunohistochemistry. PLoS One. 2020;15(2):e0228327. doi: 10.1371/journal.pone.0228327
   PubMed Web of Science ®Google Scholar
• Tewari D, Steward D, Fasnacht M, et al. Detection by real-time quaking-induced conversion (RT-QuIC), ELISA, and IHC of chronic wasting disease prion in lymph nodes from Pennsylvania white-tailed deer with specific PRNP genotypes. J Vet Diagn Invest. 2021;33(5):943–948. doi: 10.1177/10406387211021411
   PubMed Web of Science ®Google Scholar
• Schmitz M, Cramm M, Llorens F, et al. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc. 2016;11(11):2233–2242. doi: 10.1038/nprot.2016.120
   PubMed Web of Science ®Google Scholar
• Orrú CD, Groveman BR, Raymond LD, et al. Bank vole prion protein as an apparently Universal substrate for RT-QuIC-Based detection and discrimination of prion strains. PLOS Pathog. 2015;11(6):e1004983. doi: 10.1371/journal.ppat.1004983
   PubMed Web of Science ®Google Scholar
• Orrú CD, Groveman BR, Foutz A, et al. Ring trial of 2nd generation RT-QuIC diagnostic tests for sporadic CJD. Ann Clin Transl Neurol. 2020;7(11):2262–2271. doi: 10.1002/acn3.51219
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Iwasaki Y, Takekoshi A, et al. An autopsy-verified case of FTLD-TDP type a with upper motor neuron-predominant motor neuron disease mimicking MM2-thalamic-type sporadic Creutzfeldt-Jakob disease. Prion. 2016;10(6):492–501. doi: 10.1080/19336896.2016.1243192
   PubMed Web of Science ®Google Scholar
• Cracco L, Appleby BS, Gambetti P. Fatal familial insomnia and sporadic fatal insomnia. Handb Clin Neurol. 2018;153:271–299.
   PubMedGoogle Scholar
• Hermann P, Schmitz M, Cramm M, et al. Application of real-time quaking-induced conversion in Creutzfeldt-Jakob disease surveillance. J Neurol. 2023;270:2149–2161. doi: 10.1007/s00415-022-11549-2
   PubMedGoogle Scholar
• Hayashi Y, Iwasaki Y, Yoshikura N, et al. An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay. Prion. 2017;11(4):284–292. doi: 10.1080/19336896.2017.1345416
   PubMed Web of Science ®Google Scholar
• Zanusso G, Monaco S, Pocchiari M, et al. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease. Nat Rev Neurol. 2016;12:325–333. doi: 10.1038/nrneurol.2016.65
   PubMed Web of Science ®Google Scholar
• Nakagaki T, Kaneko M, Satoh K, et al. Detection of prions in a cadaver for anatomical practice. N Engl J Med. 2022;386(23):2245–2246. doi: 10.1056/NEJMc2204116
   PubMed Web of Science ®Google Scholar
• Yuan Q, Rowden G, Wolf TM, et al. Sensitive detection of chronic wasting disease prions recovered from environmentally relevant surfaces. Environ Int. 2022;166:107347. doi: 10.1016/j.envint.2022.107347
   PubMed Web of Science ®Google Scholar
• Mok TH, Nihat A, Majbour N, et al. Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease. Brain. 2023;146(6):2570–2583. doi: 10.1093/brain/awad101
   PubMed Web of Science ®Google Scholar
• Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004;56(5):702–708. doi: 10.1002/ana.20261
   PubMed Web of Science ®Google Scholar
• Atarashi R, Moore RA, Sim VL, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods. 2007;4(8):645–650. doi: 10.1038/nmeth1066
   PubMed Web of Science ®Google Scholar
• Watson N, Hermann P, Ladogana A, et al. Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease. JAMA Netw Open. 2022;5(1):e2146319. doi: 10.1001/jamanetworkopen.2021.46319
   PubMed Web of Science ®Google Scholar
• Love S, Chalmers K, Ince P, et al. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis. 2014;3:19–32.
   PubMedGoogle Scholar
• Krasnianski A, Meissner B, Schulz-Schaeffer W, et al. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2006;63(6):876–880. doi: 10.1001/archneur.63.6.876
   PubMedGoogle Scholar
• Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133(10):3043–3057. doi: 10.1093/brain/awq216
   PubMedGoogle Scholar
• Gadjusek DC, Zigas VK. Clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of new Guinea. Am j med. 1959;26:442–469. doi: 10.1016/0002-9343(59)90251-7
   PubMed Web of Science ®Google Scholar
• Collinge J, Whitfield J, McKintosh E, et al. Kuru in the 21st century–an acquired human prion disease. Lancet. 2006;367:2068–2074. doi: 10.1016/S0140-6736(06)68930-7
   PubMed Web of Science ®Google Scholar
• Duffy P, Wolf J, Collins G, et al. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974;290:692–693.
   PubMed Web of Science ®Google Scholar
• Koch TK, Berg BO, De Armond SJ, et al. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med. 1985;313:731–733. doi: 10.1056/NEJM198509193131206
   PubMed Web of Science ®Google Scholar
• Brown P, Brandel JP, Sato T, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18:901–917. doi: 10.3201/eid1806.120116
   PubMed Web of Science ®Google Scholar
• Tee BL, Longoria Ibarrola EM, Geschwind MD. Prion diseases. Neurol Clin. 2018;36(4):865–897. doi: 10.1016/j.ncl.2018.07.005
   PubMed Web of Science ®Google Scholar
• Llorens F, Villar-Piqué A, Hermann P, et al. Diagnostic accuracy of prion disease biomarkers in Iatrogenic Creutzfeldt-Jakob disease. Biomolecules. 2020;10(2):290. doi: 10.3390/biom10020290
   PubMed Web of Science ®Google Scholar
• Sakai K, Hamaguchi T, Sanjo N, et al. Diffusion-weighted magnetic resonance imaging in dura mater graft-associated Creutzfeldt-Jakob disease. J Neurol Sci. 2020;418:117094. doi: 10.1016/j.jns.2020.117094
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Asano M, Mohri S, et al. A traceback phenomenon can reveal the origin of prion infection. Neuropathology. 2009;29(5):619–624. doi: 10.1111/j.1440-1789.2008.00973.x
   PubMed Web of Science ®Google Scholar
• Doh-Ura K, Kitamoto T, Sakaki Y, et al. CJD discrepancy. Nature. 1991;353(6347):801–802. doi: 10.1038/353801b0
   PubMed Web of Science ®Google Scholar
• Rudge P, Jaunmuktane Z, Adlard P, et al. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain. 2015;138(11):3386–3399. doi: 10.1093/brain/awv235
   PubMedGoogle Scholar
• Wells GA, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec. 1987;121(18):419–420. doi: 10.1136/vr.121.18.419
   PubMed Web of Science ®Google Scholar
• Collee JG, Bradley R. BSE: a decade on–part I. Lancet. 1997;349:636–641. doi: 10.1016/S0140-6736(96)01310-4
   PubMed Web of Science ®Google Scholar
• Collee JG, Bradley R. BSE: a decade on–part 2. Lancet. 1997;349:715–721. doi: 10.1016/S0140-6736(96)08496-6
   PubMedGoogle Scholar
• Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921–925. doi: 10.1016/S0140-6736(96)91412-9
   PubMed Web of Science ®Google Scholar
• Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol. 2003;24:1560–1569.
   PubMed Web of Science ®Google Scholar
• Ritchie DL, Peden AH, Barria MA. Variant CJD: reflections a quarter of a century on. Pathogens. 2021;10(11):1413. doi: 10.3390/pathogens10111413
   PubMed Web of Science ®Google Scholar
• Ironside JW, McCardle L, Horsburgh A, et al. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS. 2002;110(1):79–87. doi: 10.1034/j.1600-0463.2002.100110.x
   PubMed Web of Science ®Google Scholar
• Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. 2000;47(5):575–582. doi: 10.1002/1531-8249(200005)47:5<575:AID-ANA4>3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004;363(9407):417–421. doi: 10.1016/S0140-6736(04)15486-X
   PubMed Web of Science ®Google Scholar
• Risk assessment of the transmission of vCJD by blood components. London: Department of Health and Social Care; 2019. [cited 2023 Aug 5]; Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/843533/risk-assessment-of-the-transmission-of-vcjd-by-blood-components.pdf
   Google Scholar
• Mok T, Jaunmuktane Z, Joiner S, et al. Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP codon 129. N Engl J Med. 2017;376:292–294.
   PubMed Web of Science ®Google Scholar
• Williams ES, Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis. 1980;16(1):89–98. doi: 10.7589/0090-3558-16.1.89
   PubMed Web of Science ®Google Scholar
• Benestad SL, Telling GC. Chronic wasting disease: an evolving prion disease of cervids. Handb Clin Neurol. 2018;153:135–151.
   PubMedGoogle Scholar
• Expanding Distribution of Chronic Wasting Disease 2023 Jul 5. Madison (WI): National Wildlife Health Center, The U.S Geological Survey. [cited 2023 Aug 5]; Available from: https://www.usgs.gov/centers/nwhc/science/expanding-distribution-chronic-wasting-disease.
   Google Scholar
• Pritzkow PS. Transmission, Strain diversity, and zoonotic potential of chronic wasting disease. Viruses. 2022;14(7):1390. doi: 10.3390/v14071390
   PubMed Web of Science ®Google Scholar
• Mathiason CK, Powers JG, Dahmes SJ, et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science. 2006;314(5796):133–136. doi: 10.1126/science.1132661
   PubMed Web of Science ®Google Scholar
• Tamgüney G, Miller MW, Wolfe LL, et al. Asymptomatic deer excrete infectious prions in faeces. Nature. 2009;461(7263):529–532. doi: 10.1038/nature08289
   PubMed Web of Science ®Google Scholar
• Haley NJ, Seelig DM, Zabel MD, et al. Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay. PLoS One. 2009;4(3):e4848. doi: 10.1371/journal.pone.0004848
   PubMed Web of Science ®Google Scholar
• Otero A, Duque Velasquez C, McKenzie D, et al. Emergence of CWD strains. Cell Tissue Res. 2023;392(1):135–148. doi: 10.1007/s00441-022-03688-9
   PubMed Web of Science ®Google Scholar
• Belay ED, Gambetti P, Schonberger LB, et al. Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol. 2001;58(10):1673–1678. doi: 10.1001/archneur.58.10.1673
   PubMedGoogle Scholar
• Davis, JP, Kazmierczak J, Wegner M, et al. Fatal Degenerative Neurologic Illnesses in Men Who Participated in Wild Game Feasts --- Wisconsin, 2002, Morbidity and Mortality Weekly Report. Atlanta: Centers for disease Control and Prevention (CDC); 2003;52(07):12–127. [Accessed 2023 Aug 5]. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5207a1.htm
   Google Scholar
• Anderson CA, Bosque P, Filley CM, et al. Colorado surveillance program for chronic wasting disease transmission to humans: lessons from 2 highly suspicious but negative cases. Arch Neurol. 2007;64(3):439–441. doi: 10.1001/archneur.64.3.439
   PubMedGoogle Scholar
• Abrams JY, Maddox RA, Harvey AR, et al. Travel history, hunting, and venison consumption related to prion disease exposure, 2006–2007 FoodNet population survey. J Am Diet Assoc. 2011;111:858–863. doi: 10.1016/j.jada.2011.03.015
   PubMedGoogle Scholar
• Race B, Meade-White KD, Miller MW, et al. Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis. 2009;15(9):1366–1376. doi: 10.3201/eid1509.090253
   PubMed Web of Science ®Google Scholar
• Race B, Meade-White KD, Phillips K, et al. Chronic wasting disease agents in nonhuman primates. Emerg Infect Dis. 2014;20(5):833–837. doi: 10.3201/eid2005.130778
   PubMed Web of Science ®Google Scholar
• Race B, Williams K, Orrú CD, et al. Lack of transmission of chronic wasting disease to cynomolgus macaques. J Virol. 2018;92:e00550–18. doi: 10.1128/JVI.00550-18
   PubMed Web of Science ®Google Scholar
• Race B, Baune C, Williams K, et al. Second passage experiments of chronic wasting disease in transgenic mice overexpressing human prion protein. Vet Res. 2022;53(1):111. doi: 10.1186/s13567-022-01130-0
   PubMedGoogle Scholar
• Wang Z, Qin K, Camacho MV, et al. Generation of human chronic wasting disease in transgenic mice. Acta Neuropathol Commun. 2021;9(1):158. doi: 10.1186/s40478-021-01262-y
   PubMed Web of Science ®Google Scholar